logo
Share SHARE
FONT-SIZE Plus   Neg

STAAR Surgical Says It Can Now Market ICL With CentraFlow Technology In India

STAAR Surgical Company (STAA), a maker of implantable lenses and delivery systems for the eye, Monday said it received the regulatory nod to market its Visian Implantable Collamer Lens or ICL with CentraFlow technology, in India.

The company said the approval from CDSCO will help expand its market in India where there has been a 48% compound annual growth rate for the Visian ICL, over the last four years. 

Don Todd, President of the Asia Pacific Region for STAAR Surgical said, "Our marketing partner, Spica Medical, has seen a lot of anticipation in the market for the CentraFLOW technology as inquiries from surgeons and clinics over the past few weeks have been tremendous. With this approval in India, we can now leverage this growing acceptance to further penetrate a significantly large market."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The recent week marked the lull before the storm, with very few market moving economic numbers released during the week. However, the economic news flow picks up pace in the upcoming week, offering glimpses into every vehicle of economic growth, ranging from consumers to private sector activity to housing.... Life expectancy at birth in the U.S. is already lower than most other developed nations and is now projected to fall further behind by 2030, according to a new study. It also suggests that by 2030, national female life expectancy in South Korea could break the 90 year barrier. Department store chain J.C. Penney Co. Inc. on Friday reported a turnaround to profit in the fourth quarter as a slight decline in sales was more than offset by lower expenses. Adjusted earnings per share for the quarter beat analysts' expectations, while revenues slightly missed their estimates. Earlier today, J.C. Penny announced a plan to optimize its national retail operations.
comments powered by Disqus
Follow RTT